Hydroxyphenyl Butanone Induces Cell Cycle Arrest through Inhibition of GSK3


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2021
Historique:
received: 01 04 2021
revised: 30 04 2021
accepted: 15 06 2021
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 23 9 2021
Statut: epublish

Résumé

Colorectal cancer (CRC) is among the top three gastrointestinal malignancy in morbidity and mortality. The abnormal activation of Wnt/ Cell proliferation was detected after hydroxyphenyl butanone treatment in human colorectal cancer HCT116, LOVO, and normal colonic epithelial NCM460 cells. Colony formation, cell invasion ability, and cell cycle were detected with and without GSK-3 Hydroxyphenyl butanone induces cycle arresting on G1-S phase of colorectal cancer cell line through GSK3 This study illustrated natural hydroxyphenyl butanone as new inhibitor of GSK3

Sections du résumé

BACKGROUND BACKGROUND
Colorectal cancer (CRC) is among the top three gastrointestinal malignancy in morbidity and mortality. The abnormal activation of Wnt/
METHODS METHODS
Cell proliferation was detected after hydroxyphenyl butanone treatment in human colorectal cancer HCT116, LOVO, and normal colonic epithelial NCM460 cells. Colony formation, cell invasion ability, and cell cycle were detected with and without GSK-3
RESULTS RESULTS
Hydroxyphenyl butanone induces cycle arresting on G1-S phase of colorectal cancer cell line through GSK3
CONCLUSION CONCLUSIONS
This study illustrated natural hydroxyphenyl butanone as new inhibitor of GSK3

Identifiants

pubmed: 34307685
doi: 10.1155/2021/9981815
pmc: PMC8272657
doi:

Substances chimiques

Butanones 0
Plant Extracts 0
Glycogen Synthase Kinase 3 beta EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9981815

Informations de copyright

Copyright © 2021 Songyan Zhang et al.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
J Neurosci Res. 2005 May 1;80(3):360-8
pubmed: 15789403
EMBO J. 1997 Jul 1;16(13):3797-804
pubmed: 9233789
Gut. 2013 Apr;62(4):540-9
pubmed: 22798500
Food Chem Toxicol. 2007 May;45(5):725-32
pubmed: 17321025
Int J Biochem Cell Biol. 2018 Nov;104:55-65
pubmed: 30195065
Sci Rep. 2018 May 21;8(1):7924
pubmed: 29784906
Nat Prod Res. 2020 Feb;34(4):599-603
pubmed: 30417669
Life Sci. 2005 May 27;77(2):194-204
pubmed: 15862604
Med Oncol. 2012 Jun;29(2):919-27
pubmed: 21390519
Oncogene. 2019 Jan;38(4):564-580
pubmed: 30166592
Rev Prat. 2015 Jun;65(6):802-6
pubmed: 26298904
Bull World Health Organ. 2009 Sep;87(9):707-13
pubmed: 19784451
Nutr Cancer. 2006;56(1):86-94
pubmed: 17176222
J Med Food. 2004 Winter;7(4):450-5
pubmed: 15671688
Genome Med. 2018 Apr 17;10(1):30
pubmed: 29665865
Cancer Res. 2019 Oct 1;79(19):4896-4910
pubmed: 31431461
Eur J Cancer. 2010 Mar;46(4):765-81
pubmed: 20116997
Cancer Res. 1998 Mar 15;58(6):1130-4
pubmed: 9515795
Nutr Cancer. 2009;61(6):816-26
pubmed: 20155622
Am J Transl Res. 2016 Jul 15;8(7):3077-86
pubmed: 27508028
Clin Cancer Res. 2019 Oct 1;25(19):5947-5960
pubmed: 31285371
J Food Sci Technol. 2014 Nov;51(11):3369-75
pubmed: 26396333
Cell. 2000 Oct 13;103(2):311-20
pubmed: 11057903
Food Funct. 2014 Dec;5(12):3241-51
pubmed: 25322288
BMC Complement Altern Med. 2014 Aug 16;14:304
pubmed: 25129221
Cancer Prev Res (Phila). 2009 Jul;2(7):665-72
pubmed: 19584078
Curr Biol. 1998 May 7;8(10):573-81
pubmed: 9601641
Nat Rev Cancer. 2003 Oct;3(10):768-80
pubmed: 14570043
Oncotarget. 2017 Oct 26;8(58):97787-97800
pubmed: 29228651
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):559-565
pubmed: 27833172
Carcinogenesis. 2011 Mar;32(3):343-50
pubmed: 21098643
Science. 1996 May 17;272(5264):1023-6
pubmed: 8638126
J Med Food. 2012 May;15(5):495-503
pubmed: 22551412
Food Funct. 2014 Jul 25;5(7):1513-9
pubmed: 24836598
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
Br J Nutr. 2013 Jan 14;109(1):33-42
pubmed: 22716201
J Med Food. 2012 Mar;15(3):258-68
pubmed: 22082102

Auteurs

Songyan Zhang (S)

Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.

Yunfeng Wang (Y)

Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

Haopeng Zhang (H)

Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

Chengming Sun (C)

Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.

Shuwei Dang (S)

Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

Ming Liu (M)

Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH